Vimarsana
Biggest News Aggregation in the World

Page 5 - Mark Massaro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Massaro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Massaro Today - Breaking & Trending Today

Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript - Vimarsana News

Bionano Genomics (BNGO) Q2 2023 Earnings Call Transcript

BNGO earnings call for the period ending June 30, 2023.

Source: fool.com
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2023 Earnings Call Transcript - Vimarsana News

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.

Exact Sciences (EXAS) Q2 2023 Earnings Call Transcript - Vimarsana News

Exact Sciences (EXAS) Q2 2023 Earnings Call Transcript

EXAS earnings call for the period ending June 30, 2023.

Source: fool.com
BTIG Sticks to Its Buy Rating for Guardant Health (GH) - Vimarsana News

BTIG Sticks to Its Buy Rating for Guardant Health (GH)

BTIG analyst Mark Massaro maintained a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $50.00. Th...

Renalytix Kidney Disease Test Gets FDA Clearance - Vimarsana News

Renalytix Kidney Disease Test Gets FDA Clearance

The test, which assesses predictive blood-based biomarkers and electronic health record data, was first introduced in the US in late 2020 as a laboratory-developed test.

Source: 360dx.com